ALDOSTERONE AND INTERLEUKIN-6: IS IT A NEW ASSOCIATION IN COVID-19?

被引：0
|
作者：
Campana, P.
Ranieri, A.
Basile, C.
Forzano, I.
Perillo, E.
Ciaramella, L.
Follero, P.
Tagliamonte, G.
Sibilio, G.
机构：
[1] UNIV NAPOLI FEDERICO II, Naples, Italy
[2] PO SANTA MARIA DELLA GRAZIE, Pozzuoli, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷 / SUPPL C期
关键词：
D O I：
10.1093/eurheartj/suac012.391
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P405
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients
    Iglesias-Gonzalez, Maria
    Boigues, Marc
    Sanagustin, David
    Giralt-Lopez, Maria
    Cuevas-Esteban, Jorge
    Martinez-Caceres, Eva
    Diez-Quevedo, Crisanto
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2022, 19
  • [42] Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19
    Sertoglu, Erdim
    Yucel, Cigdem
    Balik, Ahmet Rifat
    Tasci, Canturk
    Bilge, Sedat
    Ertugrul, Meryem Sebla
    Nazaroglu, Namik Kemal
    Ozgurtas, Taner
    NUTRITION, 2022, 96
  • [43] Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19
    Kruglova, Tatyana S.
    Fomina, Darya S.
    Poteshkina, Nataliya G.
    Frolova, Nadija F.
    Beloglazova, Irina P.
    Mutovina, Zinaida Yu
    Samsonova, Inna, V
    Kovalevskaja, Elena A.
    Zagrebneva, Alena, I
    Serdotetckova, Sofya A.
    Chernov, Anton A.
    Lysenko, Maryana A.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (11) : 1316 - 1324
  • [44] Interleukin-6: A versatile Biomarker in the clinical Chemistry Laboratory in the COVID-19 Era
    Basu, Surupa
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (12) : BC01 - BC5
  • [45] The pathophysiological implications of interleukin-6 concentrations associated with COVID-19 in human trophoblasts
    Matic, Milos
    Obradovic, Ana
    Paunovic, Milica
    Ognjanovic, Branka
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1144 - 1144
  • [46] The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series
    Tadepalli, Satish
    Vanjarapu, Jagan Mohan Rao
    De Dona, Anna
    Cheriyath, Pramil
    Nookala, Vinod
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [47] Interleukin-6 and severe COVID-19: a systematic review and meta-analysis
    Helia Mojtabavi
    Amene Saghazadeh
    Nima Rezaei
    European Cytokine Network, 2020, 31 : 44 - 49
  • [48] Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
    Smetana, Karel, Jr.
    Brabek, Jan
    IN VIVO, 2020, 34 : 1589 - 1592
  • [49] Interleukin-6 blocking agents for treating COVID-19: a living systematic review
    Ghosn, Lina
    Chaimani, Anna
    Evrenoglou, Theodoros
    Davidson, Mauricia
    Grana, Carolina
    Schmucker, Christine
    Bollig, Claudia
    Henschke, Nicholas
    Sguassero, Yanina
    Nejstgaard, Camilla Hansen
    Menon, Sonia
    Thu Van Nguyen
    Ferrand, Gabriel
    Kapp, Philipp
    Riveros, Carolina
    Avila, Camila
    Devane, Declan
    Meerpohl, Joerg J.
    Rada, Gabriel
    Hrobjartsson, Asbjorn
    Grasselli, Giacomo
    Tovey, David
    Ravaud, Philippe
    Boutron, Isabelle
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [50] Elevated interleukin-6 is associated with severity of COVID-19: A meta-analysis
    Zhu, Jieyun
    Pang, Jielong
    Ji, Pan
    Zhong, Zhimei
    Li, Hongyuan
    Li, Bocheng
    Zhang, Jianfeng
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 35 - 37
12345